Financial Gravity Asset Management, Inc. Vertex Pharmaceuticals Inc Transaction History

Financial Gravity Asset Management, Inc.

$400 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 26, 2024	SELL	$407.69 - $446.08 $2,038 - $2,230	-5 Reduced 41.67%	7 $2.93 Million
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $8,561 - $9,367	21 Added 190.91%	32 $13.4 Million
Q4 2023 Jun 26, 2024	SELL	$343.0 - $410.68 $6,860 - $8,213	-20 Reduced 62.5%	12 $5.13 Million
Q3 2023 Nov 15, 2023	SELL	$338.18 - $362.46 $115,319 - $123,598	-341 Reduced 96.88%	11 $3,000
Q2 2023 Aug 08, 2023	BUY	$314.42 - $351.91 $11,633 - $13,020	37 Added 11.75%	352 $4.57 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $7,363 - $8,400	26 Added 9.0%	315 $4.61 Million
Q4 2022 Feb 15, 2023	SELL	$285.76 - $321.48 $2.24 Million - $2.52 Million	-7,831 Reduced 96.44%	289 $4.03 Million
Q3 2022 Nov 03, 2022	SELL	$273.83 - $305.53 $93,102 - $103,880	-340 Reduced 4.02%	8,120 $4.45 Million
Q2 2022 Aug 05, 2022	BUY	$234.96 - $292.55 $148,024 - $184,306	630 Added 8.05%	8,460 $4.6 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $1.1 Million - $1.3 Million	4,970 Added 173.78%	7,830 $4.83 Million
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $505,009 - $637,502	2,853 Added 40757.14%	2,860 $1.62 Million
Q2 2021 Aug 11, 2021	SELL	$187.49 - $221.1 $749 - $884	-4 Reduced 36.36%	7 $202,000
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $6,831 - $7,963	-33 Reduced 75.0%	11 $2.37 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $9,108 - $12,147	44 New	44 $10,000
Q2 2020 Aug 13, 2020	SELL	$225.48 - $295.8 $66,967 - $87,852	-297 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$199.77 - $247.81 $41,152 - $51,048	-206 Reduced 40.95%	297 $70,000
Q4 2019 Feb 28, 2020	SELL	$166.71 - $223.91 $41,844 - $56,201	-251 Reduced 33.29%	503 $219,000
Q3 2019 Oct 15, 2019	SELL	$166.23 - $187.09 $27,760 - $31,244	-167 Reduced 18.13%	754 $128,000
Q2 2019 Jul 26, 2019	SELL	$164.61 - $190.37 $32,428 - $37,502	-197 Reduced 17.62%	921 $169,000
Q1 2019 Apr 19, 2019	SELL	$163.73 - $194.7 $35,365 - $42,055	-216 Reduced 16.19%	1,118 $208,000
Q3 2018 Oct 31, 2018	BUY	$167.73 - $192.74 $35,894 - $41,246	214 Added 19.11%	1,334 $227,000
Q2 2018 Aug 14, 2018	SELL	$145.72 - $169.96 $13,989 - $16,316	-96 Reduced 7.89%	1,120 $196,000
Q1 2018 May 23, 2018	BUY	$151.6 - $177.13 $184,345 - $215,390	1,216 New	1,216 $182,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.4 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.5 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.89 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.29 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.

Account